In a filing, INmune Bio Inc revealed its Chief Financial Officer Moss David J acquired Company’s shares for reported $52868.0 on Sep 30 ’24. In the deal valued at $5.29 per share,10,000 shares were bought. As a result of this transaction, Moss David J now holds 1,285,869 shares worth roughly $12.55 million.
Then, Tesi Raymond Joseph bought 15,380 shares, generating $98,048 in total proceeds. Upon buying the shares at $6.38, the President and CEO now owns 1,554,106 shares.
Before that, Moss David J bought 7,690 shares. INmune Bio Inc shares valued at $49,024 were divested by the Chief Financial Officer at a price of $6.38 per share. As a result of the transaction, Moss David J now holds 1,275,869 shares, worth roughly $12.45 million.
Rodman & Renshaw initiated its INmune Bio Inc [INMB] rating to a Buy in a research note published on January 28, 2025; the price target was $23. A number of analysts have revised their coverage, including Alliance Global Partners’s analysts, who began to cover the stock in late October with a ‘”a Buy”‘ rating. Raymond James began covering INMB with “an Outperform” recommendation on September 27, 2024. Scotiabank started covering the stock on August 22, 2024. It rated INMB as “a Sector outperform”.
Price Performance Review of INMB
On Monday, INmune Bio Inc [NASDAQ:INMB] saw its stock fall -3.94% to $9.76. Over the last five days, the stock has gained 23.39%. INmune Bio Inc shares have risen nearly 108.99% since the year began. Nevertheless, the stocks have fallen -18.19% over the past one year. While a 52-week high of $14.74 was reached on 01/31/25, a 52-week low of $4.32 was recorded on 01/02/25. SMA at 50 days reached $5.79, while 200 days put it at $7.17.
Levels Of Support And Resistance For INMB Stock
The 24-hour chart illustrates a support level at 9.27, which if violated will result in even more drops to 8.79. On the upside, there is a resistance level at 10.26. A further resistance level may holdings at 10.77. The Relative Strength Index (RSI) on the 14-day chart is 74.53, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.85, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 12.83%. Stochastics %K at 89.64% indicates the stock is a selling.
How much short interest is there in INmune Bio Inc?
A steep rise in short interest was recorded in INmune Bio Inc stocks on 2025-01-15, growing by 1.04 million shares to a total of 5.03 million shares. Yahoo Finance data shows the prior-month short interest on 2024-12-13 was 4.0 million shares. There was a rise of 20.57%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on June 01, 2023 when Robert W. Baird began covering the stock and recommended ‘”an Outperform”‘ rating along with a $16 price target.
